Katharina Lechner

2.0k total citations · 1 hit paper
73 papers, 1.2k citations indexed

About

Katharina Lechner is a scholar working on Physiology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Katharina Lechner has authored 73 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 15 papers in Hematology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Katharina Lechner's work include Diet and metabolism studies (12 papers), Mast cells and histamine (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). Katharina Lechner is often cited by papers focused on Diet and metabolism studies (12 papers), Mast cells and histamine (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). Katharina Lechner collaborates with scholars based in Germany, Switzerland and United States. Katharina Lechner's co-authors include Benjamin Lechner, Amy L. McKenzie, Johannes Scherr, Ronald M. Krauss, Nicolai Worm, Clemens von Schacky, Uwe Nixdorff, Nicolle Kränkel, Martin Halle and Peter Bettelheim and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Katharina Lechner

63 papers receiving 1.2k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors

2019 238 citations Katharina Lechner, Clemens von Schacky et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katharina Lechner Germany	19	295	247	228	180	164	73	1.2k
Anna Stelmaszczyk‐Emmel Poland	16	239 0.8×	271 1.1×	283 1.2×	83 0.5×	128 0.8×	84	1.2k
Eman Abdel Rahman Ismail Egypt	22	265 0.9×	222 0.9×	106 0.5×	167 0.9×	130 0.8×	110	1.4k
Jasper J. van Doormaal Netherlands	21	160 0.5×	183 0.7×	325 1.4×	159 0.9×	134 0.8×	44	1.3k
Yo Han Ahn South Korea	17	346 1.2×	233 0.9×	115 0.5×	141 0.8×	76 0.5×	99	1.5k
Michel Tsimaratos France	22	550 1.9×	244 1.0×	411 1.8×	104 0.6×	56 0.3×	67	1.7k
O Linderkamp Germany	20	262 0.9×	170 0.7×	155 0.7×	59 0.3×	64 0.4×	67	1.1k
Mariann I. Lassenius Finland	14	282 1.0×	253 1.0×	120 0.5×	102 0.6×	109 0.7×	40	870
Bogna Wierusz‐Wysocka Poland	20	251 0.9×	165 0.7×	195 0.9×	434 2.4×	154 0.9×	113	1.3k
Katarzyna Korybalska Poland	19	239 0.8×	246 1.0×	123 0.5×	71 0.4×	82 0.5×	71	1.4k
Michael R. Preusch Germany	20	287 1.0×	122 0.5×	275 1.2×	72 0.4×	256 1.6×	58	1.3k

Countries citing papers authored by Katharina Lechner

Since Specialization

Citations

This map shows the geographic impact of Katharina Lechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Lechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Lechner more than expected).

Fields of papers citing papers by Katharina Lechner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Lechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Lechner. The network helps show where Katharina Lechner may publish in the future.

Co-authorship network of co-authors of Katharina Lechner

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Lechner. A scholar is included among the top collaborators of Katharina Lechner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Lechner. Katharina Lechner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lechner, Katharina, et al.. (2024). Hitze und kardiovaskuläres Risiko. PuSH - Publication Server of Helmholtz Zentrum München. 18(2). 120–126. 1 indexed citations

Jamois, Candice, Koorosh Korfi, Sylvia Herter, et al.. (2024). Integrated Quantitative Clinical Pharmacology Analysis Identifies Optimal Englumafusp Alfa Dose Range for Proof-of-Concept Study with Glofitamab in Second-Line Large B-Cell Lymphoma Patients. Blood. 144(Supplement 1). 4180–4180.

Lechner, Katharina, Pia von Korn, Stephan Mueller, et al.. (2024). Cardiometabolic and immune response to exercise training in patients with metabolic syndrome: retrospective analysis of two randomized clinical trials. Frontiers in Cardiovascular Medicine. 11. 1329633–1329633.

Schacky, Clemens von, Johannes Scherr, E Lorenz, et al.. (2023). De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients. Journal of Clinical Medicine. 12(15). 4938–4938. 2 indexed citations

Ferreira, Cláudia S., Irina Klaman, Oliver Krieter, et al.. (2023). Predictive potential of angiopoietin-2 in a mCRC subpopulation treated with vanucizumab in the McCAVE trial. Frontiers in Oncology. 13. 1157596–1157596. 8 indexed citations

Lechner, Katharina, Clemens von Schacky, Johannes Scherr, et al.. (2022). Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial. Biomedicines. 10(9). 2296–2296. 6 indexed citations

Dickinson, Michael, Javier Briones, Alex F. Herrera, et al.. (2021). Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma. Blood Advances. 5(22). 4762–4770. 29 indexed citations

Lechner, Katharina, Johannes Scherr, E Lorenz, et al.. (2021). Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial. Clinical Research in Cardiology. 111(3). 308–321. 16 indexed citations

Cavalier, Étienne, Julien Guiot, Katharina Lechner, et al.. (2021). Circulating Nucleosomes as Potential Markers to Monitor COVID-19 Disease Progression. Frontiers in Molecular Biosciences. 8. 600881–600881. 31 indexed citations

10.

Lechner, Katharina & Heribert Schunkert. (2021). Personalisierte Behandlungskonzepte bei arterieller Hypertonie. Herz. 46(1). 91–104. 1 indexed citations

11.

Lechner, Katharina, Benjamin Lechner, Alexander Crispin, Peter E. H. Schwarz, & Helene von Bibra. (2021). Waist-to-height ratio and metabolic phenotype compared to the Matsuda index for the prediction of insulin resistance. Scientific Reports. 11(1). 8224–8224. 32 indexed citations

12.

Athinarayanan, Shaminie J., Sarah J. Hallberg, Amy L. McKenzie, et al.. (2021). Correction to: Impact of a 2‑year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes. Cardiovascular Diabetology. 20(1). 37–37. 1 indexed citations

13.

Lechner, Katharina, Amy L. McKenzie, Nicolle Kränkel, et al.. (2020). High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation. Metabolic Syndrome and Related Disorders. 18(4). 176–185. 100 indexed citations

14.

Lechner, Katharina, WU Li-ya, Elisa Waldmann, et al.. (2018). A Walnut-Enriched Diet Affects Gut Microbiome in Healthy Caucasian Subjects: A Randomized, Controlled Trial. Nutrients. 10(2). 244–244. 101 indexed citations

15.

Lechner, Katharina, et al.. (2017). A Walnut-Enriched Diet Reduces Lipids in Healthy Caucasian Subjects, Independent of Recommended Macronutrient Replacement and Time Point of Consumption: a Prospective, Randomized, Controlled Trial. Nutrients. 9(10). 1097–1097. 51 indexed citations

16.

Mitterbauer, Margit, Gerlinde Mitterbauer, Oskar A. Haas, et al.. (1995). Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia. Annals of Hematology. 71(4). 155–160. 1 indexed citations

17.

Lechner, Katharina, C Korninger, H. Niessner, et al.. (1987). [Oral anticoagulant therapy--renaissance of an old therapy?].. PubMed. 99(7). 203–10. 1 indexed citations

18.

Gschnait, Fritz, et al.. (1973). [Kasabach-Merritt syndrome].. PubMed. 24(12). 522–8. 1 indexed citations

19.

Ehringer, H, et al.. (1970). Thrombolytische Therapie nicht akuter arterieller Verschlüsse. DMW - Deutsche Medizinische Wochenschrift. 95(12). 610–615. 4 indexed citations

20.

Lechner, Katharina, et al.. (1968). [The importance of plasma- pheresis during intensive postoperative care in hemophilia].. PubMed. 17(3). 72–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact